Turnover: 1.6 million EUR (2023)
Country: France
- I75% of all emerging human infectious diseases originate from animals and birds.
- Ceva's animal health group works to prevent diseases present in animals, particularly those that are potentially dangerous for humans.
News
How Ceva Santé Animale became a world leader 22/04/2024
**Sales**: 1.6 billion euros
**R&D investment**: Nearly 10% of sales, with a budget approaching 150 million euros this year.
**Number of industrial sites**: 25 industrial sites, including 7 in France.
**Number of subsidiaries**: 47 subsidiaries.
**International presence**: 110 countries.
**Percentage of sales in France**: Only 8%
**Number of employee shareholders**: 2,000 out of 7,000.
**Recent acquisition**: Scout Bio, a start-up specialized in gene therapy, in the United States.
**Growth strategy**: Specialization in prevention, mainly vaccines, and debt-financed acquisitions to reach a critical size of around 8 million euros to be profitable.
Health: Ceva strengthens its position in the pet market 09/02/2024
- Ceva Santé Animale is the world's no. 5 in veterinary medicine.
- Ceva Santé Animale has acquired the American company Scout Bio.
- Ceva's sales in 2022 were 1.5 billion euros.
- The companion animal market represents over 40% of the US animal health market, and a quarter of its European equivalent.
- Ceva Santé Animale has a presence in France, employing 1,600 people.
Ceva Santé Animale strengthens its position in Latin America with a double acquisition 06/03/2023
- Ceva Santé Animale is the leading laboratory dedicated to animal health in France and the fifth worldwide.
- The laboratory generated sales of €1.4 billion in 2021, 90% of which outside France.
- Acquisition of two Argentine companies, Zoovet, specialized in the production and marketing of animal health products, and the start-up Biotecnofe, which develops innovative products for Zoovet.
- Zoovet has five manufacturing sites, and a portfolio of 595 livestock products
- It employs 200 people.
- Ceva has become the fifth largest player in this market, with sales of around €35 million.
- Argentina remains one of the world's leading livestock producers, with nearly fifteen million head of cattle.
- Ceva achieves sales of over €200 million in Latin America
- By 2022, Ceva Santé Animale had acquired the Canadian company Artemis Technologies and created a joint venture with the Mitsui Group to expand into Japan.
Financial Data
DUNS: 301763405
Legal Name: CEVA SANTE ANIMALE
Address: 10 AV DE LA BALLASTIERE , 33500 LIBOURNE
Number of employees: Entre 1 000 et 1 999 salariés (2021)
Capital: 40 682 183 EUR
Financial Data:
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 759 639 000 | 756 515 000 | 663 173 000 | 622 404 000 | 576 005 000 | 533 085 000 | 439 474 000 | 373 066 000 | 309 255 000 |
| Gross margin (€) | 553 627 000 | 559 447 000 | 480 037 000 | 459 428 000 | 424 947 000 | 750 495 000 | 340 113 000 | 545 196 000 | 228 253 000 |
| EBITDA (€) | 173 651 000 | 210 171 000 | 148 765 000 | 101 212 000 | 143 377 000 | 42 848 000 | 76 499 000 | 27 138 000 | 47 872 000 |
| Operating profit (€) | 115 320 000 | 154 084 000 | 80 550 000 | 56 481 000 | 119 266 000 | 89 240 000 | 58 030 000 | 53 826 000 | 39 956 000 |
| Net profit (€) | 71 327 000 | 94 496 000 | 33 054 000 | 23 982 000 | 72 430 000 | 63 259 000 | 36 091 000 | 19 215 000 | 31 860 000 |
| Turnover growth rate (%) | 0,4 | 14,1 | 6,6 | 8,1 | 8,1 | 21,3 | 17,8 | 20,6 | 7,2 |
| Ebitda margin rate (%) | 22,9 | 27,8 | 22,4 | 16,3 | 24,9 | 8 | 17,4 | 7,3 | 15,5 |
| Operating margin rate (%) | 15,2 | 20,4 | 12,1 | 9,1 | 20,7 | 16,7 | 13,2 | 14,4 | 12,9 |
| Working Capital (turnover days) | -60,5 | -60 | -87 | -69,8 | 70,4 | -0,2 | -88,6 | -62,6 | -90,7 |
| Working Capital requirements (turnover days) | 108,2 | 127,6 | 117,2 | 129,6 | 120 | -0,1 | 22,7 | 21 | 25,4 |
| Net margin (%) | 9,4 | 12,5 | 5 | 3,9 | 12,6 | 11,9 | 8,2 | 5,2 | 10,3 |
| Added value / Turnover (%) | 36,8 | 40,1 | 38,3 | 33,7 | 39,1 | 166,5 | 34,3 | 174 | 32 |
| Wages and social charges (€) | 111 730 000 | 104 410 000 | 106 297 000 | 106 956 000 | 87 839 000 | -85 034 000 | 80 627 000 | -55 193 000 | 56 029 000 |
| Salaries / Turnover (%) | 14,7 | 13,8 | 16 | 17,2 | 15,2 | -16 | 18,3 | -14,8 | 18,1 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Directeur général délégué | Jerome | Loret | 60 | |
| Administrateur | Valerie | Foucher | 60 | |
| Administrateur | Marc, Dominique | Prikazsky | 65 | |
| Administrateur | Marie-dominique | Biscaye | 56 |
Studies mentioning this company
The pet market - France
Other companies mentioned:
- Animalis
- Zoo Plus
- ITM Equipement (Bricorama, Bricomarché, Brico Cash)
- Truffaut
- Jardiland (Groupe Teract)
- Dalma
- Botanic
- Pets at Home
- Nestlé Purina Petcare
- Mars Petcare
- Royal Canin (Mars Petcare)
- Santé Vet - Vetassur
- Tomojo
- Acheel
- Zolux
- La Compagnie des Animaux
- Zoovet
- Topzoo
- Maxi Zoo France (groupe Fressnapf)
- Zoomalia
- Bitiba France (Zooplus)
- Zooplus
- MSD Santé Animale France (Merck)
- Ceva Santé Animale
- Nutréa Nutrition Animale NNA
- Eizhy
- Lapsa Laboratoire